I have been taking fluvoxamine 50 mg at bedtime for one week; can I discontinue it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Stop Fluvoxamine 50mg After One Week?

Yes, you can safely stop fluvoxamine 50mg after only one week of use without tapering. After such a short duration of treatment, the risk of discontinuation syndrome is minimal, and abrupt cessation is generally well-tolerated.

Why Tapering Is Not Necessary After One Week

The evidence clearly shows that discontinuation syndrome with fluvoxamine is primarily a concern with longer-term use. While fluvoxamine is associated with discontinuation syndrome 1, this risk increases substantially with duration of treatment. Research specifically examining fluvoxamine discontinuation studied patients who had been on the medication for 7-8 months, not one week 2.

The FDA label emphasizes monitoring for discontinuation symptoms and gradual dose reduction "when discontinuing treatment" 3, but this guidance is written for the general case of established therapy. After only 7 days of 50mg at bedtime, you have not been on the medication long enough for:

  • Significant neuroadaptation to occur
  • Steady-state concentrations to fully establish
  • Physical dependence to develop

Understanding Discontinuation Risk

Discontinuation syndrome characteristics include dizziness, fatigue, nausea, headaches, sensory disturbances (paresthesias), anxiety, irritability, and agitation 1, 3. However, these symptoms are reported "following missed doses or acute discontinuation of shorter-acting SSRIs" in patients on established therapy 1.

In the study of abrupt fluvoxamine withdrawal, 86% of patients developed new symptoms, but these patients had been treated for 8 months 2. The symptoms peaked at Day 5 post-discontinuation in this chronic use population.

Practical Approach

Simply stop taking the medication. No taper is required after one week at 50mg.

Monitor yourself for 5-7 days after stopping for any emergence of:

  • Dizziness or lightheadedness
  • Headache
  • Nausea
  • Irritability or mood changes

If any symptoms do emerge (which is unlikely after such brief exposure), they should be:

  • Mild and self-limiting
  • Resolve within several days
  • Manageable with supportive care

Important Caveats

Contact your prescriber to inform them you're stopping, as they should be aware of medication changes and may want to discuss:

  • Why you're discontinuing (side effects, lack of benefit, other reasons)
  • Alternative treatment options if the medication was prescribed for a specific indication
  • Whether the underlying condition requires different management

Do not apply this guidance to longer treatment durations. If you had been taking fluvoxamine for weeks or months, gradual tapering would be strongly recommended 3. The FDA specifically states "a gradual reduction in the dose rather than abrupt cessation is recommended whenever possible" for established treatment 3.

This is specific to fluvoxamine monotherapy. If you're taking other psychiatric medications, don't make changes without medical guidance.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.